Blehm Alexander, Schurr Paulus, Sorokin Vitaly A, Zianikal Ioanna, Kamiya Hiroyuki, Albert Alexander, Lichtenberg Artur
J Heart Valve Dis. 2014 Jan;23(1):9-16.
The benefit of valve-sparing aortic root replacement compared to conventional aortic root replacement surgery remains unclear.
Between February 2009 and November 2010, a total of 112 patients underwent aortic root surgery at the Department of Cardiovascular and Thoracic Surgery, Heinrich-Heine-University, Dusseldorf, Germany. The valve-sparing technique was used when leaflets were grossly normal. In cases where the valve could not be saved, a prosthetic or biological substitute was used for the aortic root, according to existing guidelines. The patients were allocated to three groups: (i) valve-sparing aortic root replacement group using the David technique (VSR-David; n = 47); (ii) valve-replacing aortic root surgery with a prosthetic conduit using the Bentall-Kuchucus technique (VRR-Prosthetic; n = 31); and (iii) valve-replacing aortic root surgery with a biological stentless valve with the full root technique (VRR-Bio; n = 34).
Intraoperative data revealed that, in the VSR-David group, the cardiopulmonary bypass and cross-clamp times were significantly longer (207 +/- 68 min and 140 +/- 38 min respectively; both p = 0.001). The VRR-Prosthetic patients were at highest risk (mean EuroSCORE 15.9%) compared to the VSR-David and VRR-Bio groups (10.8% and 10.4%, respectively). Postoperative analysis showed that patients in the VRR-Bio group had the lowest number of perioperative heart failures (p = 0.004). The perioperative 30-day mortality was significantly higher in the VRR-Prosthetic group (22.6%; p = 0.004). Transaortic flow velocities were significantly lower in the VSR-David group, followed by the VRR-Bio group and VRR-Prosthetic group (1.66 +/- 0.54, 1.98 +/- 0.45, and 2.29 +/- 0.39 m/s, respectively; p = 0.012). The univariate and multivariate analyses of perioperative risk factors showed that only open distal anastomosis was strongly associated with negative results, but not the valve-sparing technique.
Aortic valve-sparing root replacement must be considered as an excellent alternative for young patients requiring aortic root replacement when a biological valve is clinically indicated. For patients aged >65 years, or with a decreased life expectancy, the full root technique with a stentless valve should be used, given its technical simplicity and excellent postoperative results.
保留瓣膜的主动脉根部置换术与传统主动脉根部置换手术相比,其优势尚不清楚。
2009年2月至2010年11月期间,德国杜塞尔多夫海因里希 - 海涅大学心血管与胸外科共有112例患者接受了主动脉根部手术。当瓣膜大体正常时采用保留瓣膜技术。在瓣膜无法保留的情况下,根据现有指南,使用人工或生物替代品置换主动脉根部。患者被分为三组:(i)采用大卫技术的保留瓣膜主动脉根部置换组(VSR - David;n = 47);(ii)采用本塔尔 - 库楚克斯技术使用人工血管的置换瓣膜主动脉根部手术组(VRR - Prosthetic;n = 31);(iii)采用全根部技术使用生物无支架瓣膜的置换瓣膜主动脉根部手术组(VRR - Bio;n = 34)。
术中数据显示,VSR - David组的体外循环和主动脉阻断时间明显更长(分别为207±68分钟和140±38分钟;p均 = 0.001)。与VSR - David组和VRR - Bio组(分别为10.8%和10.4%)相比,VRR - Prosthetic组患者的风险最高(平均欧洲心脏手术风险评估系统评分为15.9%)。术后分析表明,VRR - Bio组围手术期心力衰竭的患者数量最少(p = 0.004)。VRR - Prosthetic组围手术期30天死亡率明显更高(22.6%;p = 0.004)。VSR - David组的经主动脉血流速度明显更低,其次是VRR - Bio组和VRR - Prosthetic组(分别为1.66±0.54、1.98±0.45和2.29±0.39米/秒;p = 0.012)。围手术期危险因素的单因素和多因素分析表明,只有开放远端吻合与不良结果密切相关,而不是保留瓣膜技术。
对于临床需要置换主动脉根部的年轻患者,当有生物瓣膜指征时,保留主动脉瓣膜的根部置换术应被视为一种极佳的替代方案。对于年龄>65岁或预期寿命降低的患者,鉴于其技术简单且术后效果良好,应采用带无支架瓣膜的全根部技术。